Navigation Links
Poll of Infection Prevention and Control Professionals Reveals MRSA Prevention Progress Six Months After National Survey
Date:12/10/2007

IPCPs Adopting Stronger Interventions but Say Facilities Must Do More

WASHINGTON, Dec. 11 /PRNewswire-USNewswire/ -- A poll of infection prevention professionals conducted six months after the Association for Professionals in Infection Control and Epidemiology's (APIC's) national MRSA Prevalence Study indicated that while 59 percent of the 2,100 who responded are adopting or have already adopted interventions to address Methicillin-resistant Staphylococcus aureus (MRSA), 50 percent said their health care facility is not doing as much as it could or should to stop the transmission of MRSA.

MRSA is a virulent multi-drug resistant organism. Interventions adopted ranged from increased hand hygiene compliance and testing of high-risk groups to the more comprehensive approach outlined in APIC's Guide to the Elimination of MRSA Transmission in Hospital Settings.

"We took this informal poll of our membership to get a sense of the pace of progress and what's changed in the six months since our MRSA Prevalence Study," said Kathy L. Warye, Chief Executive Officer of APIC. "We are encouraged that many hospitals are empowering infection prevention professionals to implement more MRSA prevention measures. However, it's concerning that many infection prevention programs are still inadequately funded and that facilities lack resources, staff and buy-in from senior management to prevent the transmission of MRSA."

Two recent studies have brought increased attention to MRSA. In June, APIC released the first national MRSA Prevalence Study which is being published in the December issue of the American Journal of Infection Control. This was followed by a CDC report published in the Journal of the American Medical Association in October.

"Our members understand the severity of this issue and are aggressively addressing MRSA, but the scope of this public health threat demands commitment and participation from every hospital, at all levels of the facility," said Denise Murphy, president of APIC and Vice President of Safety and Quality, and Chief Patient Safety and Quality Officer at Barnes-Jewish Hospital at Washington University Medical Center in St. Louis. "Hospitals should commit the resources to conduct a thorough risk assessment of patient populations and implement viable strategies to prevent MRSA and other antimicrobial-resistant infections."

APIC guidelines for the elimination of MRSA transmission include a risk assessment to identify high-risk areas for MRSA within the hospital; surveillance program to outline activities and procedures to identify MRSA cases; adherence to CDC hand hygiene guidelines; use of contact precautions (e.g., gloves, gowns and separating MRSA patients from other patients); environmental and equipment cleaning and decontamination, especially items that are close to patients such as bedrails and bedside equipment, and targeted active surveillance cultures (testing of high-risk groups).

"What health care leaders need to understand is that these interventions represent pennies on the dollar compared to the costs of infections once they occur. Reducing these infections saves both lives and scarce resources," said Warye. "APIC will conduct a thorough, formal study with our members in six months, and at that time we expect to see many more facilities in compliance with national guidelines."

Published in the December 2007 issue of the American Journal of Infection Control, the APIC MRSA Prevalence Study offers the most comprehensive understanding of MRSA to date. The study revealed that MRSA is significantly more widespread throughout health care facilities and across every state.

Findings demonstrate MRSA prevalence rates to be 46 in 1,000 patients, eight times higher than previous estimates. Of those, approximately 34/1,000 were infected while 12/1,000 patients were colonized. The APIC study was the first study to measure rates of both MRSA infection and colonization (patients carrying and able to transmit MRSA), to more accurately determine MRSA prevalence.

For more details on the study, including a full copy of the AJIC article, polling questions and results, and sample unedited comments from ICPs polled, please visit http://www.apic.org/Content/NavigationMenu/ResearchFoundation/NationalMRSAP revalenceStudy/MRSA_Study_Results.htm.

APIC's mission is to improve health and patient safety by reducing risks of infection and other adverse outcomes. The Association's more than 11,000 members have primary responsibility for infection prevention, control and hospital epidemiology in health care settings around the globe. APIC advances its mission through education, research, collaboration, practice guidance, public policy, and credentialing. Visit APIC online at http://www.apic.org


'/>"/>
SOURCE Association for Professionals in Infection Control andEpidemiology
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
2. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
3. Computers help chemists fight emerging infections
4. Infection contributes to the high rates of oropharyngeal cancers
5. Jefferson immunology researchers halt lethal rabies infection in brain
6. SIV infection of natural hosts provides new insights into HIV disease complexity
7. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
8. Natural aorta grafts have few side effects for infection-prone patients
9. Common misdiagnosis: most women believe they have a yeast infection when they dont
10. Patient Safety Authority Board of Directors Names Infection Advisory Panel
11. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites vigilance ... research related to Zika virus during pregnancy, as well as other prenatal exposures ... science. , The Teratology Society is an international and multidisciplinary ...
(Date:4/25/2017)... ... ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace – from ... be heartened by the industry’s current surge. But another thing that unifies them is ... At last they can simply, safely and effectively end their aroma anguish thanks to ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... of predictive analytics to its patient care management module. Using this new feature, ... a patient has been initiated on continuous positive airway pressure (CPAP), oral, or ...
(Date:4/25/2017)... , ... April 25, 2017 , ... There is no ... Hospital, according to a special report in the May issue of Consumer Reports focused ... highest quality ranking for results achieved during and after coronary bypass and aortic valve ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, ... its strategic partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a ... effective management of complex spine deformity cases, particularly in children. , GSO’s focus ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... April 21, 2017 Halo Labs announces the ... particle analysis system called the Horizon at PEGS 2017 ... The new system analyzes sub visible particulate matter in ... particle screening as early as candidate selection and pre-formulation. ... biopharma contract research organization Elion Labs for ...
(Date:4/20/2017)... 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... announced that it will be participating in the Deutsche ... InterContinental Hotel in Boston, Massachusetts ... at 11:20 a.m. Eastern Time. A live ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  The ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
Breaking Medicine Technology: